CIK 0001817241 · <br>Emerging growth company
Artiva Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARTV
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863614316
- Phone
- (858) 267-4467
- Business address
- 5505 MOREHOUSE DRIVE, SAN DIEGO, CA, 92121
- 4 Open-market sale Chief Executive Officer sold 61,888 shares at $11.16 ($690,392)
- 4 Planned sale Chief Medical Officer sold 8,222 shares at $12.01 ($98,736)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Medical Officer sold 429 shares at $12.00 ($5,148)
- 144 Insider Sale of Securities
- EFFECT Other Notice of Effectiveness
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 4 Open-market buy Director bought 45,768 shares at an average $9.96 ($455,726)
- 4 Open-market buy Director bought 41,319 shares at $9.99 ($412,777)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 264,586 shares at an average $9.76 ($2,583,314)
- 4/A Open-market buy Director bought 6,522 shares at $8.94 ($58,307)
- 8-K Event Other events
- 4 Open-market buy Director bought 160,354 shares at an average $8.93 ($1,432,119)
Page 3 of 12 · 234 filings